Grape King Bio reported a consolidated revenue of NT$4.82 billion for the first half of the year, a year-on-year decrease of 5.57%, due to weakened overall consumer spending. Revenue in June reached NT$880 million, representing a 6.79% increase from the previous month and remaining flat compared to the same period last year. The company anticipates that revenue in the second half will be boosted by the launch of new products, continuing its historical trend of stronger performance in the latter half of the year. All operational plans are proceeding as scheduled, and the company maintains its full-year growth target for consolidated performance.

Breaking down the performance by business unit, Grape King Bio’s parent company in Taiwan saw a 38.55% month-on-month increase and a 35.07% year-on-year increase in June revenue. First-half revenue rose 14.19% year-on-year. Contract manufacturing was the primary growth driver, with strong shipment momentum from overseas OEM clients. Revenue from OEM in June surged 122.82% year-on-year, and both second-quarter and first-half results showed double-digit growth compared to the same periods last year, reflecting outstanding performance.

Grape King Bio’s official e-commerce platform, “Buy Health,” collaborated with major e-commerce sites during the 6.18 mid-year health supplement promotion period, helping to drive sales growth. Meanwhile, Grape King's multi-level marketing subsidiary, Pro-Partner, faced a decline in newly recruited members in the first half of the year. Combined with macroeconomic headwinds affecting consumer confidence and spending, Pro-Partner posted a 3.21% month-on-month increase but a 4.42% year-on-year decline in June revenue. Its cumulative revenue for the first half of the year fell 7.48% year-on-year. However, with the industry entering its peak season in the third quarter and a series of new product launches expected, revenue contribution in the second half is projected to support a positive growth trajectory.

Resource: 葡萄王 全年業績展望不變